InflaRx NV (IFRX)
1.29
-0.09
(-6.52%)
USD |
NASDAQ |
May 06, 16:00
1.30
+0.01
(+0.78%)
After-Hours: 20:00
InflaRx Profit Margin (Quarterly): -696.8K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -696.8K% |
| Date | Value |
|---|---|
| September 30, 2023 | -12.26K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-696.8K%
Minimum
Dec 2023
-12.26K%
Maximum
Sep 2023
-354.5K%
Average
-354.5K%
Median
Profit Margin (Quarterly) Benchmarks
| Affimed NV | -4.89K% |
| MorphoSys AG | 81.70% |
| BioNTech SE | 30.96% |
| Immatics NV | -164.2% |
| CureVac NV | -384.0% |
Profit Margin (Quarterly) Related Metrics
| Gross Profit Margin (Quarterly) | -12.02K% |
| Operating Margin (Quarterly) | -582.0K% |